Circulating MicroRNAs Implicate Multiple Atherogenic Abnormalities in the Long-Term Cardiovascular Sequelae of Preeclampsia. (23rd May 2018)

• Record Type: Journal Article
• Authors: Dayan, Natalie; Schlosser, Kenny; Stewart, Duncan J; Delles, Christian; Kaur, Amanpreet; Pilote, Louise
• Is Part Of: American journal of hypertension. Volume 31:Number 10(2018:Oct.)
• Page Start: 1093
• Page End: 1097
• Publication Date: 2018-05-23
• Subjects: acute coronary syndrome -- blood pressure -- cardiovascular disease -- hypertension -- microRNA -- preeclampsia; Hypertension -- Periodicals; 616.132005
• DOI: 10.1093/ajh/hpy069
• Languages: English
• ISSNs: 0895-7061

Abstract

Abstract: BACKGROUND: Women who have had preeclampsia (PE) are at increased risk for premature cardiovascular disease (CVD). The underlying pathophysiology of this risk remains unclear, but potentially involves subclinical vascular damage or dysfunction. Alterations in the levels of circulating microRNAs may be implicated, as they are known to play pervasive roles in vascular biology. We investigated whether levels of circulating microRNAs are altered between women with premature acute coronary syndrome (ACS), with and without a history of PE. METHODS: Women with premature ACS (age ≤ 55 years) were categorized based on a prior history of PE or normotensive pregnancy. Relative plasma levels of 372 microRNAs were initially assessed by polymerase chain reaction array in a subset of subjects ( n = 12–13/group) matched for age, chronic hypertension, dyslipidemia, and smoking status. Candidate microRNAs were then validated in a larger cohort of ACS patients ( n = 176). RESULTS: MicroRNAs previously linked to angiogenesis (miR-126-3p), inflammation (miR-146a-5p), and cholesterol metabolism (miR-122-5p) were significantly decreased in women with prior PE compared to women with prior normotensive pregnancy ( P = 0.002, 0.017, and 0.009, respectively), even after adjustment for chronic hypertension. CONCLUSIONS: Circulating levels of miR-126-3p, -146a-5p, and -122-5p were significantly decreased in women with premature ACS who reported prior PE compared to those with prior normotensive pregnancy. These data provide novel insight into potential pathways that may contribute to the increased risk of CVD following PE.